October 18, 2026 
3 min read 
Recent positive vaccine results from major biopharma created strong market interest in adjacent plays, prompting a search for companies that pair biology with accelerated discovery workflows. Iambic emerged as a candidate because it explicitly integrates advanced machine learning with automated laboratories to shorten the design-test-learn cycle, making it a near-term thematic play on AI-enabled drug discovery.
Trade Setup
Ticker
IAM
Price
Target 1
Progress
Feed